
ES Doce 120 Injection Combipack
Marketer
Esperer Bioresearch Pvt Ltd
Salt Composition
Docetaxel (120mg)
Overview ES Doce 120 Injection Combipack
The combination injection, ES Doce 120, is a chemotherapy agent indicated for various cancers, including breast, non-small cell lung, prostate, and head and neck malignancies. Administration is strictly by injection from a qualified healthcare provider. Dosage and frequency are determined individually by your physician based on your specific condition and may be adjusted over time. Adhere precisely to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits may not be apparent for weeks or months; discontinue only under your doctor's guidance. Common side effects include fatigue, constipation, swelling, infections, appetite loss, myalgia, nail abnormalities, pain, and general weakness. Concomitant medications may be prescribed to mitigate these effects. Report any unusual bruising, bleeding, sore throat, mouth sores, or fever to your physician immediately. This medication can suppress blood cell production (red and white blood cells), increasing infection risk. Regular blood tests are necessary to monitor blood counts and liver function. Prior to commencing treatment, disclose any pre-existing heart, liver, or kidney conditions, or concurrent use of other medications, especially antibiotics or antifungals, to your doctor. Interactions with numerous other drugs are possible. This medication is contraindicated during pregnancy and breastfeeding. Reliable contraception is crucial for both partners during treatment to prevent conception.
Primary Ingredients of ES Doce 120 Injection Combipack
No information provided. Please provide the text you wish me to rephrase.
Uses of ES Doce 120 Injection Combipack
Cancers of the breast, lung (non-small cell), prostate, and head and neck.
Major Benefits of ES Doce 120 Injection Combipack:
The medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
Common Side effects of ES Doce 120 Injection Combipack:
- Breathlessness
- Constipation
- Edema (swelling)
- Infection
- Loss of appetite
- Muscle pain
- Nail disorder
- Pain
- Weakness
How to use ES Doce 120 Injection Combipack:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How ES Doce 120 Injection Combipack works:
ES Doce 120 Injection Combipack is a cancer treatment that disrupts the microtubule networks essential for cancer cell division and proliferation. This inhibits cancer cell growth, leading to their eventual demise.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of ES Doce 120 Injection Combipack and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Employing ES Doce 120 Injection Combipack during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might consider its use if the potential advantages outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of ES Doce 120 Injection Combipack while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingCONSULT YOUR DOCTOR
The effect of ES Doce 120 Injection Combipack on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
ES Doce 120 Injection Combipack poses no safety concerns for patients with renal impairment; therefore, no dosage alteration is necessary.
LiverCAUTION
Exercise caution when administering the ES Doce 120 Injection Combipack to individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is recommended.
What if you forget to take ES Doce 120 Injection Combipack :
NA
Facts to Know About ES Doce 120 Injection Combipack
| Label | Value |
|---|---|
| Chemical Type | Taxane Derivatives |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | Taxanes: Antimicrotubule Agents |
